Quick Answer
PUMA BIOTECHNOLOGY, INC. reported Shares Outstanding of 50.41 million shares for fiscal year 2025.
PUMA BIOTECHNOLOGY, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 50.41M | +2.7% |
| 2024 | 49.11M | +3.1% |
| 2023 | 47.65M | +2.8% |
| 2022 | 46.35M | +12.6% |
| 2021 | 41.18M | +2.7% |
| 2020 | 40.09M | +2.3% |
| 2019 | 39.20M | +2.3% |
| 2018 | 38.33M | +1.9% |
| 2017 | 37.59M | +2.1% |
| 2016 | 36.83M | +13.4% |
| 2015 | 32.47M | +6.3% |
| 2014 | 30.55M | +5.4% |
| 2013 | 28.99M | +1.1% |
| 2012 | 28.68M | +43.1% |
| 2011 | 20.04M | +401.0% |
| 2010 | 4.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 50.38M | +2.7% | +1.0% |
| June 30, 2025 | 49.89M | +3.0% | +0.6% |
| March 31, 2025 | 49.62M | +2.9% | +1.0% |
| December 31, 2024 | 49.11M | +3.1% | +0.1% |
| September 30, 2024 | 49.07M | +3.2% | +1.3% |
| June 30, 2024 | 48.46M | +3.2% | +0.5% |
| March 31, 2024 | 48.21M | +3.3% | +1.2% |
| December 31, 2023 | 47.65M | +2.8% | +0.2% |
- PUMA BIOTECHNOLOGY, INC. showed an increase of +2.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, PUMA BIOTECHNOLOGY, INC.’s shares outstanding has grown by 1160.2% (from 4.00 million shares to 50.41 million shares).
- The most recent figure is from PUMA BIOTECHNOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: